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Abstract 
We present a patient who developed progressive neurological disease caused by lesions 
histologically compatible with those observed in subacute brainstem angioencephalopathy. 
The patient was treated with low-molecular weight heparin, and treatment response was 
monitored clinically and with MRI. Anticoagulation therapy stopped progression of the 
neurological deficit and led to improvement of MRI findings. This report further supports the 
existence of subacute brainstem angioencephalopathy as a characteristic disease entity and 
gives insight into possible therapeutic approach with anticoagulation treatment.  
 
 4 
Introduction 
 
Subacute diencephalic or brainstem angioencephalopathy is a rare clinical entity with 
progressive course, and usually leads to death within few months after symptoms onset. We 
present a patient with subacute brainstem angioencephalopathy, whose condition significantly 
improved on anticoagulation therapy.  
 
 
Case presentation 
 
 
Otherwise healthy, 30-year-old male patient presented to our emergency room because of 
speech difficulties and clumsiness of the right hand. First symptoms started two days before 
with very subtle right hand clumsiness. Neurological examination revealed dysarthric speech 
and paresis of the right arm (muscle strength was 4/5), the rest of the neurological 
examination was normal. Multi-sliced computed tomography (MSCT) of the brain showed an 
hypodense lesion with irregular rim at the left side of the pons, without contrast enhancement. 
Brain MRI showed hyperintense lesion on T2 weighted sequences (dimensions 1.6x2 cm) in 
the left pons with spreading to left crus cerebri and minimal post –gadolinium enhancement 
(Fig. 1). DWI sequences showed significantly low diffusion and signs of microhaemorrhages 
were present. Cell blood count (CBC), standard laboratory, and coagulation tests were 
normal. ECG and chest X-ray were unremarkable. CSF examination revealed one 
lymphocyte, slightly elevated proteins of 0.40 g/l (normal value < 0.37), normal CSF protein 
electrophoresis, and absent oligoclonal bands. Serum and CSF serology for Varicella, 
Toxoplasmosis, Rubella, Mumps, Morbilli, Mycoplasma pneumoniae, HSV 1 and 2, EBV, 
CMV, Adenovirus, Borrelia burgdorferi, Syphilis, hepatitis B and C, and HIV were negative. 
CSF cultures for tuberculosis, candida, aspergilus and cryptococcus were negative as well. 
Tumor markers (AFP, CEA, CYFRA 21-1, beta HCG, anti Hu, Yo and Ri antibodies), 
immunologic tests (IgG, IgA, IgM, beta2-microglobulin,  ANA, cardiolipin antibodies IgM 
and IgG, RF, ANCA, CH 50, C3, C4) were all negative. Vascular risk factors (hypertension, 
hypercholesterolemia, cigarette smoking) were not present. 
Corticosteroid treatment (methylprednisolone 500 mg per day) was initiated, however on the 
second day after hospitalization patient’s condition worsened. His speech was severely 
dysarthric and dysphonic, he had saccadic eye movements, severe paresis of the right arm 
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(muscle strength 2/5) and severe dysmetria of the right leg. Two days later he further 
worsened, he had complete plegia of the right arm and positive Babisnki sign with brisk 
reflexes on the right extremities. Because he was now unable to walk low-molecular heparin – 
enoxaparin 0.6 ml was administered subcutaneously together with dexamethasone 16 mg. 
After this therapy his condition stabilized.  
To clarify the etiology of the pontine lesion stereotactic biopsy was performed before 
anticoagulation treatment was started. Histopathology showed small edematous CNS tissue 
fragments with multiple small sized areas of complete and incomplete necrosis (Fig. 2D) with 
old blood remnants. A striking microangiopathy with severe fibrosis of small and middle 
sized veins and single arteries (Fig. 2B, 2E) as well as some vascular occlusions (Fig. 2C, 2F) 
were observed. Inflammatory infiltrates were not present. These changes were reminiscent to 
those described in subacute brainstem / diencephalic angioencephalopathy, but other causes of 
microangiopathy (e.g. collagenosis, thrombotic thrombocytopenic purpura) were 
histologically not excluded.  
Control brain MRI performed after the biopsy showed reduction of the lesion, there was still 
hyperintense T2 lesion in the left pons, however with lesser degree of edema and smaller 
lesion in the middle cerebellar peduncules (Fig. 1). MRI angiography performed on 3 Tesla 
MRI was normal. We additionally did protein C and S analysis, and factor V Leyden 
(R506Q), factor II (G2021A), MELAS (MTTL! A3243G and T3271C) and MERF (MTTK 
A8344G) mutation analysis, which were negative.  
The patient was referred to rehabilitation and showed progressive improvement in the 
following six weeks. His speech was discreetly dysarthric, he had full right arm movements 
with weakness of the finger extensors, and he could walk without help. Anticoagulation 
therapy was continued. 
 
Discussion 
 
Foix–Alajouanine syndrome consists of subacute myelopathy secondary to thrombosis of 
abnormal vascular channels in which venous congestion causes progressive subacute 
myelopathy.[1] A cranial variant of this syndrome has been described in 4 cases with lesions 
in a symmetrical diencephalic distribution and typical histopathological findings.[2-5] 
Characteristically, all patients were in the older age groups, sufferd from progressive 
neurological deficit which eventually lead to death in the time course of 2-3 months. A single 
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case of subacute brainstem angioncephalopthy has been described in a 69-year old male 
patient.[6] Histopathological findings were also consistent with subacute diencephalic 
angioencephalopathy. Characteristic pathology in this patient affected veins, and venous 
hypertension due to outflow obstruction is sufficient to explain the subacute progressive 
course and the type of parenchymal damage.[6] Characteristic histopathological findings of 
striking microangiopathy with severe fibrosis of small and middle sized veins and single 
arteries, as well as some vascular occlusions without inflammatory infiltrates were also 
present in our patient. Although these findings could not exclude other disease like 
collagenosis and thrombotic thrombocytopenic purpura (TTP), these are very unlikely after 
extensive laboratory examinations and absence of other signs or symptoms. 
Another striking feature in our patient was disease stabilization on anticoagulation therapy. 
This may be due to prevention of new vascular occlusions. All other described cases were 
treated with corticosteroids, with little or no success. Our patient recovered extremely well, 
and showed clinical and neuroradiological improvement after six months of follow-up. 
This report further supports the existence of subacute brainstem angioencephalopathy as a 
characteristic disease entity and gives insight into possible therapeutic approaches.  
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Figure legends 
 
Figure 1 
Brain MRI on the day of the addmission (A-C): A and B) T2 weighted sequences: 
hyperintense lesion in the left pons with spreading to left crus cerebri; C) T1 weighted 
sequence after gadolinium application: note the minimal post –gadolinium enhancement. 
Brain MRI 10 days after admission (D-F): D and E) T2 weighted sequences; F) T1 weighted 
sequence after gadolinium application: Note the progression of the lesion. 
Control brain MRI after the biopsy and introduction of anticoagulation therapy (G-H): T2 
weighted sequences: hyperintense T2 lesion in the left pons, however with lesser degree of 
edema and smaller lesion in the middle cerebellar peduncules. 
Brain MRI at three month interval (I-K): I and L) T2 weighted sequences; K) T1 weighted 
sequence after gadolinium application: note further improvement. 
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Figure 2 
A: Low magnification of the stereotactic biopsy showing tiny CNS tissue fragments with 
edematous change and small foci of complete and incomplete necrosis lacking inflammatory 
infiltrates (Hematoxylin-Eosin (HE) x 40). D: Higher magnification of a necrotic area 
(Hematoxylin-Eosin x 400). B, E: Extensive fibrosis of small and middle-sized vessels, 
corresponding mostly to veins and, to a lesser extent, small arteries (B: HE x 200, E: elastica 
van Gieson x 200). C, F: Thrombotic occlusion of small and middle-sized vessels (C: HE x 
400, F: elastica van Gieson x 400). 
 
